Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.3111
+0.0281 (9.93%)
Mar 10, 2026, 1:39 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
Research and Development of Cellular Therapies | 582.00K | 68.00K | - | - | - | | |
Research and Development of Cellular Therapies Growth | 755.88% | - | - | - | - | | |
| 582.00K | 68.00K | - | - | - | | |
| 755.88% | - | - | - | - | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 582.00K | 68.00K | - | - | - | | |
| 755.88% | - | - | - | - | | |
| 582.00K | 68.00K | - | - | - | | |
| 755.88% | - | - | - | - | | |
Source: S&P Global Market Intelligence.
